These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 6252156

  • 1. Cefotaxime in bronchopulmonary infections--a clinical and pharmacological study.
    Lode H, Kemmerich B, Gruhlke G, Dzwillo G, Koeppe P, Wagner I.
    J Antimicrob Chemother; 1980 Sep; 6 Suppl A():193-8. PubMed ID: 6252156
    [No Abstract] [Full Text] [Related]

  • 2. Significance of pleural and sputum concentrations for antibiotic therapy of bronchopulmonary infections.
    Lode H, Gruhlke G, Hallermann W, Dzwillo G.
    Infection; 1980 Sep; Suppl 1():49-53. PubMed ID: 7399714
    [Abstract] [Full Text] [Related]

  • 3. The secretion of minocycline in sputum during therapy of bronchopulmonary infection in chronic chest diseases.
    Brogan TD, Neale L, Ryley HC, Davies BH, Charles J.
    J Antimicrob Chemother; 1977 May; 3(3):247-51. PubMed ID: 873874
    [No Abstract] [Full Text] [Related]

  • 4. Concentrations of cefotaxime in bronchial secretions.
    Morel C, Monrocq N, Besnard Y.
    J Antimicrob Chemother; 1980 Sep; 6 Suppl A():123-4. PubMed ID: 6252142
    [No Abstract] [Full Text] [Related]

  • 5. [Trimethoprim-sulfamethoxazole assocation in bronchopulmonary infections].
    Arouette A, Yourassowsky E, Schoutens E, De Koster JP.
    Acta Clin Belg; 1971 Sep; 26(2):106-15. PubMed ID: 5142046
    [No Abstract] [Full Text] [Related]

  • 6. [Use of antibiotics in nontuberculous bronchopulmonary diseases in adults].
    Kalb JC, Bolot JF.
    J Med Lyon; 1971 Sep 20; 52(213):1158-66. PubMed ID: 5135884
    [No Abstract] [Full Text] [Related]

  • 7. [Cefatrizine in the ambulatory treatment of recurring chronic bronchial infections].
    Fantoni U, Miglioli PA.
    Riv Eur Sci Med Farmacol; 1987 Sep 20; 9(3):327-30. PubMed ID: 3508607
    [No Abstract] [Full Text] [Related]

  • 8. [Use of antibiotics of rhinopharyngeal and bronchopulmonary diseases in children].
    Monnet.
    J Med Lyon; 1971 Sep 20; 52(213):1156-8. PubMed ID: 5135883
    [No Abstract] [Full Text] [Related]

  • 9. [Penetration of cefotaxime into bronchial secretions].
    Bergogne-Berezin E, Morel C, Pierre J, Monrocq N, Dournovo P, Benard Y.
    Pathol Biol (Paris); 1982 Jun 20; 30(6 Pt 2):501-5. PubMed ID: 6289226
    [Abstract] [Full Text] [Related]

  • 10. Cefotaxime in the treatment of lower respiratory tract infections.
    Hänninen P, Toivanen A, Vainio O, Toivanen P.
    J Antimicrob Chemother; 1980 Sep 20; 6 Suppl A():181-5. PubMed ID: 6252153
    [No Abstract] [Full Text] [Related]

  • 11. Cefotaxime in lower respiratory tract infections compared to cefazolin.
    Miki F, Shiota K.
    J Antimicrob Chemother; 1980 Sep 20; 6 Suppl A():169-75. PubMed ID: 6252151
    [No Abstract] [Full Text] [Related]

  • 12. [Efficacy and safety of cefepime in the treatment of bronchopulmonary disease exacerbation in pediatric patients with mucoviscidosis].
    Semykin SIu, Postnikov SS, Polikarpova SV, Dubovik LG, Kolbatova ES.
    Antibiot Khimioter; 2005 Sep 20; 50(4):18-22. PubMed ID: 16392335
    [Abstract] [Full Text] [Related]

  • 13. [Comparative study of the effectiveness of cefotaxime and cefazolin on respiratory tract infection (author's transl)].
    Kansenshogaku Zasshi; 1980 Sep 20; 54(9):471-517. PubMed ID: 6263989
    [No Abstract] [Full Text] [Related]

  • 14. The use of cefotaxime in pneumology.
    Grassi C, Colombo ML, Peona V.
    Acta Med Port; 1983 Feb 20; 4(2):87-90. PubMed ID: 6303060
    [No Abstract] [Full Text] [Related]

  • 15. [The efficacy of doxycycline in the treatment of respiratory infections (doxycycline levels in the serum, saliva, sputum, lung and pleural fluids) (author's transl)].
    Simon C, Sommerwerck D, Friehoff J.
    Prax Klin Pneumol; 1978 Apr 20; 32(4):266-70. PubMed ID: 643799
    [No Abstract] [Full Text] [Related]

  • 16. [Sensitivity to ampicillin of proteus causing broncho-pulmonary infections].
    Benard Y, Freymuth F.
    Therapeutique; 1970 Apr 20; 46(6):699-700. PubMed ID: 5449840
    [No Abstract] [Full Text] [Related]

  • 17. [Pneumococcal infections: penicillin resistance and therapeutic implications].
    Kamoun A, Ben Hassen A, Mahjoubi F, Ben Redjeb S.
    Tunis Med; 1995 Feb 20; 73(2):119-23. PubMed ID: 9506153
    [No Abstract] [Full Text] [Related]

  • 18. [Clinical experiences with cefoperazone. A new cephalosporine derivative for pulmonary infections].
    Liener A.
    Med Welt; 1982 Feb 05; 33(5):188-90. PubMed ID: 6461813
    [No Abstract] [Full Text] [Related]

  • 19. [Bacteriologic and clinical observations on the gentamicin effect in pneumology].
    Mariani B, Velluti G.
    G Ital Chemioter; 1969 Feb 05; 16(1):178-86. PubMed ID: 5404095
    [No Abstract] [Full Text] [Related]

  • 20. [USE OF CHLORAMPHENICOL HEMISUCCINATE IN RESPIRATORY INFECTIONS. (1ST RESULTS)].
    DUMON G, DUMON LEGRE M, VILLA J, AMICHOT JL, PINAS E.
    Mars Med; 1963 Feb 05; 100():1187-99. PubMed ID: 14102322
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.